Representative before the EPO

Employment test 51 - 200 employees
Company dna d young and co llp
operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 32 EP applications Zöe Clyde-Watson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11815953

FOAMABLE COMPOSITIONS OF STABILIZED CHLORITE

IPC classification:
A61K 47/30, A61P 17/02, A61K 33/00, A61K 9/12
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12760787

POLYPEPTIDES WITH AFFINITY FOR HEAT SHOCK PROTEINS (HSPS) AND HSP ASSOCIATED COMPLEXES (HACS) AND THEIR USE IN DIAGNOSIS AND THERAPY

IPC classification:
A61K 39/00, G01N 33/574, G01N 33/543, G01N 33/53, C12N 15/11, C07K 19/00, C07K 14/47, C07K 14/00, C07K 7/08, C07K 7/06, C07K 1/22, A61P 37/04, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted
EP12717824

DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA

IPC classification:
A61K 31/7068, A61K 31/706, A61P 35/02
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12737648

AMIDO-PYRIDYL ETHER COMPOUNDS AND COMPOSITIONS AND THEIR USE AGAINST PARASITES

IPC classification:
A61K 31/4433, A61K 31/44, A01N 37/18, C07D 213/18, A61P 33/14, A61P 33/10, A61P 33/00
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT GRANTED
EP12732700

VINYL ALCOHOL POLYMERS WITH SILANE SIDE CHAINS

IPC classification:
C08F 230/08
Agent:
HGF Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12716555

PARTICLES WITH HYDROXYL VINYLIC COPOLYMER COATING SENSITIVE TO IONIC STRENGTH

IPC classification:
C11D 17/00, C11D 3/37
Agent:
HGF Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION WITHDRAWN
EP12716553

NOVEL COMPOSITE

IPC classification:
C11D 17/00, C11D 3/37
Agent:
HGF Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION WITHDRAWN
EP12748346

JAK P13K/mTOR COMBINATION THERAPY

IPC classification:
A61K 31/7064, A61K 31/4188, A61P 35/00
Applicant:
Novartis Pharma AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12759857

DECITABINE DERIVATIVE FORMULATIONS

IPC classification:
A61K 47/20, A61K 47/10, A61K 31/7068, A61K 9/19, A61K 9/00, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12772575

PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF

IPC classification:
A61K 31/42, A01N 25/00, A61P 33/00
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12775538

BACTERIUM FOR USE AS A PROBIOTIC FOR NUTRITIONAL AND MEDICAL APPLICATIONS

IPC classification:
A61K 35/74, A61P 37/00, A61P 1/00
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12795175

METHOD OF TREATING A PROLIFERATIVE DISEASE

IPC classification:
A61K 31/506, A61P 35/00
Applicant:
Novartis AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
Sewkian Rudge, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13178264

Immunomodulation by IAP Inhibitors

IPC classification:
A61K 39/39, A61K 39/00, A61K 31/506, A61K 31/4439, A61K 31/437, A61K 31/427, A61K 31/421, A61P 37/02
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Novartis AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION REQUESTED
EP12798095

COMPOSITIONS COMPRISING AN ARYL PYRAZOLE AND A SUBSTITUTED IMIDAZOLE, METHODS AND USES THEREOF

IPC classification:
A61K 45/06, A61K 31/4164, A61K 31/415, A61P 33/14
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted
EP12798570

LONG-ACTING INJECTABLE MOXIDECTIN FORMULATIONS AND NOVEL MOXIDECTIN CRYSTAL FORMS

IPC classification:
A61K 31/365, C07D 493/22, A61P 33/00
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted
EP13189094

Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases

IPC classification:
A61K 31/407, C07D 491/04, A61P 19/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703705

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

IPC classification:
A61K 31/422, A61P 33/00
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12859684

HEPATITIS B ANTIVIRAL AGENTS

IPC classification:
A61K 31/435, C07D 241/18, C07D 211/54, A61P 31/12
Agent:
Kristina Victoria Joy Cornish, Kilburn & Strode LLP
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted
EP13707523

TOPICAL COMPOSITIONS COMPRISING FIPRONIL AND PERMETHRIN AND METHODS OF USE

IPC classification:
A61K 47/20, A61K 47/14, A61K 31/415, A61K 31/22, A01N 53/00, A01N 43/56, A61P 33/00
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP14156495

Therapeutic vaccines

IPC classification:
A61K 39/39, A61K 39/00, C07K 14/47
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12820937

LIPOSOMAL CHLORITE OR CHLORATE COMPOSITIONS

IPC classification:
A61K 33/20, A61K 9/127
Applicant:
Nuvo Research GmbH
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13714992

TREATMENT OF PROLIFERATIVE DISEASES WITH PYRIMIDODIAZEPINONES

IPC classification:
A61K 31/5513, A61K 31/551, A61K 9/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP13726299

SOLID PHASE PEPTIDE SYNTHESIS OF INSULIN USING SIDE CHAIN ANCHORED LYSINE

IPC classification:
C07K 14/62, C07K 1/04
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13778809

BIOMARKERS TO IDENTIFY PATIENTS THAT WILL RESPOND TO TREATMENT AND TREATING SUCH PATIENTS

IPC classification:
G01N 33/574, C12Q 1/68, C12N 15/11, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13727489

ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS

IPC classification:
A61K 31/593, A61K 31/421, A61K 31/196, A61K 31/137, A61K 31/047, A61P 21/02, A61P 19/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted
EP13725424

DOSAGE REGIMEN FOR SAPACITABINE AND SELICICLIB

IPC classification:
A61K 31/706, A61K 31/52, A61K 31/505, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13719345

PARASITICIDAL COMPOSITIONS COMPRISING BENZIMIDAZOLE DERIVATIVES, METHODS AND USES THEREOF

IPC classification:
A61K 31/4184, A01N 43/52, C07D 235/28, C07D 235/18, C07D 235/10
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12737037

REACTIVE EXTRACTION PROCESS FOR REGENERATION OF AMINE-BASED SOLVENTS USED FOR CARBON DIOXIDE CAPTURE

IPC classification:
B01J 31/02, B01D 53/73, B01D 53/96, B01D 53/62, B01D 53/14
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744895

WOUND DRESSINGS COMPRISING CHLORITE

IPC classification:
A61L 15/26, A61L 15/44, A61L 15/18
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11791699

NOVEL MONENSIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF PROTOZOAL INFECTIONS

IPC classification:
A61P 33/06, A61P 33/00, A61K 31/357, A61K 31/35, C07D 519/00, C07D 493/10
Applicant:
Merial, Inc.
Applicant:
Merial Limited
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Claude Bernard Lyon I (UCBL)
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT GRANTED
EP11791122

DEXAMETHASONE COMBINATION THERAPY

IPC classification:
A61P 35/00, A61K 31/573, A61K 31/5377
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT REVOKED
EP12705608

mTOR/JAK INHIBITOR COMBINATION THERAPY

IPC classification:
A61P 35/00, A61K 31/519, A61K 31/436
Applicant:
Novartis Pharma AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted

Please Sign in to use this feature